SCHEMBL4147458

SCHEMBL4147458

Nc1cnc(-c2ccccc2)[nH]c1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.58
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
MAPT P10636 2/20 0.54
ALDH1A1 P00352 1/20 0.54
HPGD P15428 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
NPY5R Q15761 2/20 0.53
SCN2A Q99250 2/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
PIN1 Q13526 1/20 0.51
KDM4E B2RXH2 1/20 0.49
CASP6 P55212 1/20 0.49
TNKS O95271 2/20 0.47
PARP1 P09874 2/20 0.47
TNKS2 Q9H2K2 2/20 0.47
POLB P06746 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HPGDS O60760 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28868937 0.79 RECQL (0.60) RECQLMEN1KMT2AMAPTALDH1A1
SCHEMBL5914151 0.78 RECQL (0.58) RECQLMEN1KMT2AMAPTALDH1A1
SCHEMBL6886838 0.78 COMT (0.68) RECQLNPY5RSCN2ANPC1RAB9A
SCHEMBL25270517 0.78 RECQL (0.63) RECQLMEN1KMT2AMAPTALDH1A1
SCHEMBL5371995 0.76 SCN2A (0.61) RECQLMEN1KMT2AALDH1A1NPY5R
SCHEMBL11666314 0.76 PIN1 (0.54) RECQLMEN1KMT2AMAPTALDH1A1
SCHEMBL11422025 0.75 PIN1 (0.62) RECQLNPY5RSCN2APIN1KDM4E
SCHEMBL15614429 0.74 RECQL (1.00) RECQLKMT2AHPGDSMN1; SMN2NPY5R
SCHEMBL3521755 0.74 RECQL (0.54) RECQLMEN1KMT2AALDH1A1HPGD
SCHEMBL1163852 0.73 RECQL (0.53) RECQLKMT2AALDH1A1NPY5RSCN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090005560-A1 PRODUCTION METHOD OF DIAMINOPYRIMIDINE COMPOUNDS AJINOMOTO CO. INC (JP) 2009-01-01 US disclosed
EP-2009003-A1 Production method of diaminopyrimidine compounds Ajinomoto Co., Inc. (JP) 2008-12-31 EP disclosed
US-20050165234-A1 Process for preparing pyrimidine compound AJINOMOTO CO. INC (JP) 2005-07-28 US disclosed
EP-1553090-A1 PROCESS FOR PRODUCING PYRIMIDINE COMPOUND Ajinomoto Co., Inc. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005560-A1 PRODUCTION METHOD OF DIAMINOPYRIMIDINE COMPOUNDS DPYD, DHPS, UMPS RECQL 1128/4885MEN1 2530/4885KMT2A 1803/4885
US-20050165234-A1 Process for preparing pyrimidine compound SERPINB1, CMA1, CTRC RECQL 357/4885MEN1 906/4885KMT2A 2756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.